SCHEMBL7763401

SCHEMBL7763401

CC(C)(C)c1cccc(NS(=O)(=O)c2cccs2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.68
ALDH1A1 P00352 4/20 0.59
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
HTT P42858 2/20 0.59
TP53 P04637 1/20 0.55
KDM4E B2RXH2 2/20 0.52
GAA P10253 2/20 0.52
TSHR P16473 2/20 0.52
PKM P14618 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 1/20 0.52
BRD4 O60885 1/20 0.52
MAPT P10636 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MAPK1 P28482 1/20 0.51
RORA P35398 1/20 0.51
RORC P51449 1/20 0.51
RORB Q92753 1/20 0.51
HSD17B10 Q99714 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259416 0.81 HPGD (1.00) HPGDALDH1A1MEN1KMT2AHTT
SCHEMBL22928148 0.80 BRS3 (0.44) HPGDALDH1A1KMT2AHTTKDM4E
SCHEMBL22928036 0.78 UQCRB (0.45) HPGDALDH1A1KMT2AHTTSMN1; SMN2
SCHEMBL8366964 0.77 ALDH1A1 (0.75) HPGDALDH1A1MEN1KMT2AHTT
SCHEMBL22928151 0.77 SLC40A1 (0.48) HPGDALDH1A1KMT2AHTTSMN1; SMN2
SCHEMBL4709087 0.76 MEN1 (0.84) HPGDALDH1A1MEN1KMT2AHTT
SCHEMBL29031229 0.76 MEN1 (0.77) HPGDALDH1A1MEN1KMT2AHTT
SCHEMBL22928145 0.76 CCR2 (0.45) HPGDALDH1A1MEN1KMT2ATP53
SCHEMBL678551 0.76 CA1 (0.65) HPGDALDH1A1MEN1KMT2AHTT
SCHEMBL30518185 0.75 HPGD (0.65) HPGDALDH1A1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 US disclosed
US-6512006-B1 Novel 3-position Nitrogen substituted 6,6- disubstituted-5, 6-dihydropyrones and related compounds possess antiviral properties WARNER-LAMBERT COMPANY 2003-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 HPGD 2861/4885ALDH1A1 1570/4885MEN1 2812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.